Purchase of Agilent 4150 Tape Station

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration is forecasting a new requirement for the purchase of an Agilent 4150 Tape Station instrument to be integrated into their whole genome sequencing DNA and sample preparation workflow. The solicitation is expected to be released on March 1, 2026, with an estimated award date of April 1, 2026. This procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS category (334516).

The estimated award value for this contract ranges from $25,000 to $250,000. Interested vendors should direct inquiries to the FDA's Acquisition Liaison at hfpacquisitions@fda.hhs.gov, which serves as the primary point of contact for this opportunity. The instrument will support the FDA's laboratory operations, with performance at the Food and Drug Administration facilities.

Forecast text

Purchase of Agilent 4150 Tape Station instrument for integrated workflow into whole genome sequencing DNA and sample preparation work

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast